Antibiotics And Pregnancy

dc.creatorSa Del Fiol F.
dc.creatorGerenutti M.
dc.creatorGroppo F.C.
dc.date2005
dc.date2015-06-26T14:06:17Z
dc.date2015-11-26T15:00:36Z
dc.date2015-06-26T14:06:17Z
dc.date2015-11-26T15:00:36Z
dc.date.accessioned2018-03-28T22:11:51Z
dc.date.available2018-03-28T22:11:51Z
dc.identifier
dc.identifierPharmazie. , v. 60, n. 7, p. 483 - 493, 2005.
dc.identifier317144
dc.identifier
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-22744447771&partnerID=40&md5=09d3f93abd12f805b46b1810b4e8b8a4
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/93091
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/93091
dc.identifier2-s2.0-22744447771
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1256179
dc.descriptionLike anybody else, pregnant women are susceptible to infections. The correct treatment of these women, however, must consider along with pathogens, the infection site and antibiotic pharmacokinetics, the fetus and possible side effects to the child. When prescribing over this special condition, the physician must remember that the prescription will affect two organism and the drug must treat the mother without affecting the fetus. Beta-lactams having a long history of use without significant deleterious effects on the fetuses still are the safest choice during pregnancy. However, considering the constant increase of multi-resistant microorganisms, the physician has been forced to use different antimicrobial agents. Usually, data regarding safety during pregnancy are very limited, which causes serious doubts during prescription. In addition, many studies regarding the safe use of antibiotics during pregnancy are inconclusive or demand more evidence. The present study is a wide revision regarding the use of antibiotics during pregnancy, considering their pharmacokinetics and the clinical experience in recent years. It also intends to assist the physician during prescription and to give information to the pharma-cists to help pregnant women.
dc.description60
dc.description7
dc.description483
dc.description493
dc.descriptionAhlfors, C.E., Unbound bilirubin associated with kernicterus: A historical approach (2000) J Pediatr, 137, pp. 540-544
dc.descriptionAndrade, S.E., Gurwitz, J.H., Davis, R.L., Chan, K.A., Finkelstein, J.A., Fortman, K., McPhillips, H., Platt, R., Prescription drug use in pregnancy (2004) Am J Obstet Gynecol, 191, pp. 398-407
dc.descriptionAselton, P., Jick, H., Milunsky, A., Hunter, J.R., Stergachis, A., First-trimester drug use and congenital disorders (1985) Obstet Gynecol, 65, pp. 451-455
dc.description(2004) Ketek - Telithromycin, , http://www.fda.gov/cder/foi/label/2004/21144_ketek_lbl.pdf, searched May, 2004
dc.description(2004) Rulide - Approved Product Information 2000, , http://www.pharma.aventis.com.au/corporate/products/pi/ Rulide%20and%20Rulide%20D.pdf, searched December
dc.descriptionBeard, C.M., Noller, K.L., O'Fallon, W.M., Kurland, L.T., Dahlin, D.C., Cancer after exposure to metronidazole (1988) Mayo Clin Proc, 63, pp. 147-153
dc.descriptionBerkovitch, M., Pastuszak, A., Gazarian, M., Lewis, M., Koren, G., Safety of the new quinolones in pregnancy (1994) Obstet Gynecol, 84, pp. 535-538
dc.descriptionBibler, M.R., Frame, P.T., Hagler, D.N., Bode, R.B., Staneck, J.L., Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections (1987) Antimicrob Agents Chemother, 31, pp. 207-212
dc.descriptionBirkenfeld, A., Anteby, S.O., The effect of ampicillin and colistin on post-Caesarean section endometritis with identification of possible risk factors (1983) Aust N Z J Obstet Gynaecol, 23, pp. 204-207
dc.descriptionBlanchard, M., Oppliger, R., Bucher, U., Positive direct Coombs' test in acute leukemias and other hemoblastoses: Relation to clavulanic acid-containing antibiotics? (1989) Schweiz Med Wschr, 14-119, pp. 39-45
dc.descriptionBoobis, A.R., Lewis, P., Drugs in pregnancy. Altered pharmacokinetics (1982) Br J Hosp Med, 28, pp. 566-573
dc.descriptionBriggs, G.G., Freeman, R.K., Yaffe, S.J., (2002) Drugs in Pregnancy and Lactation. 6th Ed., pp. 284-312. , Baltimore: Williams & Wilkins
dc.description(2004) Bristol-Myers Squibb Company: AzactamR, , http://www.fda.gov/cder/foi/label/2002/50580slr033lbl.pdf, searched May 2004
dc.descriptionBryskier, A., Ketolides-telithromycin, an example of a new class of antibacterial agents (2000) Clin Microbiol Infect, 6, pp. 661-669
dc.descriptionBush, M.R., Rosa, C., Azithromycin and erythromycin in the treatment of cervical chlamydial infection during pregnancy (1994) Obstet Gynecol, 84, pp. 61-63
dc.descriptionCampoli-Richards, D.M., Brogden, R.N., Faulds, D., Teicoplanin - A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential (1990) Drugs, 40, pp. 449-486
dc.descriptionChambers, H.S., Antimicrobial agents: Protein synthesis inhibitors and miscellaneous antibacterial agents (1996) Goodman &amp
dc.descriptionGilman's the Pharmacological Basis of Therapeutics, 9 th Ed., pp. 1239-1272. , Hardman JG, Gilman AG, Limbird LE (ed.) , McGraw-Hill
dc.descriptionChan, K.W., Ng, W.L., Gentamicin nephropathy in a neonate (1985) Pathology, 17, pp. 514-515
dc.descriptionChastre, J., Brun, P., Fourtillan, J.B., Soler, P., Basset, G., Manuel, C., Trouillet, J.L., Gibert, C., Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic (1987) Antimicrob Agents Chemother, 31, pp. 1312-1315
dc.descriptionChimura, T., Morisaki, N., Funayama, T., Matsuo, M., Clinical studies on aztreonam in perinatal use (1990) Jpn J Antibiot, 43, pp. 696-699
dc.descriptionChristensen, B., Which antibiotics are appropriate for treating bacteriuria in pregnancy? (2000) J Antimicrob Chemother, 46 (SUPPL. 1), pp. 29-34
dc.descriptionClark, P., Aztreonam (1992) Obstet Gynecol Clin North Am, 19, pp. 519-528
dc.descriptionClemett, D., Markham, A., Linezolid (2000) Drugs, 59, pp. 815-827
dc.descriptionConway, N., Birt, B.D., Streptomycin in pregnancy: Effect on the foetal ear (1965) Br Med J, 31, pp. 260-263
dc.descriptionCzeizel, A.E., Rockenbauer, M., A population-based case-control teratologic study of oral oxytetracycline treatment during pregnancy (2000) Eur J Obstet Gynecol Reprod Biol, 88, pp. 27-33
dc.descriptionCzeizel, A.E., Rockenbauer, M., Olsen, J., Use of antibiotics during pregnancy (1998) Eur J Obstet Gynecol Reprod Biol, 81, pp. 1-8
dc.descriptionCzeizel, A.E., Rockenbauer, M., Sorensen, H.T., Olsen, J., Teratogenic evaluation of oxacillin (1999) Scand J Infect Dis, 31, pp. 311-312
dc.descriptionCzeizel, A.E., Rockenbauer, M., Sorensen, H.T., Olsen, J., A population-based case-control teratologic study of oral erythromycin treatment during pregnancy (1999) Reprod Toxicol, 13, pp. 531-536
dc.descriptionCzeizel, A.E., Rockenbauer, M., Olsen, J., Sorensen, H.T., A teratological study of aminoglycoside antibiotic treatment during pregnancy (2000) Scand J Infect Dis, 32, pp. 309-313
dc.descriptionCzeizel, A.E., Rockenbauer, M., Olsen, J., Sorensen, H.T., Oral phenoxymethylpenicillin treatment during pregnancy. Results of a population-based Hungarian case-control study (2000) Arch Gynecol Obstet, 263, pp. 178-181
dc.descriptionCzeizel, A.E., Rockenbauer, M., Sorensen, H.T., Olsen, J., A population-based case-control teratologic study of oral chloramphenicol treatment during pregnancy (2000) Eur J Epidemiol, 16, pp. 323-327
dc.descriptionCzeizel, A.E., Rockenbauer, M., Sorensen, H.T., Olsen, J., The teratogenic risk of trimethoprim-sulfonamides: A population based case-control study (2001) Reprod Toxicol, 15, pp. 637-646
dc.descriptionCzeizel, A.E., Rockenbauer, M., Sorensen, H.T., Olsen, J., Use of cephalosporins during pregnancy and in the presence of congenital abnormalities: A population-based, case-control study (2001) Am J Obstet Gynecol, 184, pp. 1289-1296
dc.descriptionCzeizel, A.E., Rockenbauer, M., Sorensen, H.T., Olsen, J., A population-based case-control teratologic study of ampicillin treatment during pregnancy (2001) Am J Obstet Gynecol, 185, pp. 140-147
dc.descriptionCzeizel, A.E., Rockenbauer, M., Sorensen, H.T., Olsen, J., Augmentin treatment during pregnancy and the prevalence of congenital abnormalities: A population-based case-control teratologic study (2001) Eur J Obstet Gynecol Reprod Biol, 97, pp. 188-192
dc.descriptionDanisovicova, A., Brezina, M., Belan, S., Kayserova, H., Kaiserova, E., Hruskovic, I., Orosova, K., Matheova, E., Magnetic resonance imaging in children receiving quinolones: No evidence of quinolone-induced arthropathy. A multicenter survey (1994) Chemotherapy, 40, pp. 209-214
dc.descriptionDashe, J.S., Gilstrap III, L.C., Antibiotic use in pregnancy (1997) Obstet Gynecol Clin North Am, 24, pp. 617-629
dc.descriptionDavey, P.G., Williams, A.H., A review of the safety profile of teicoplanin (1991) Antimicrob Chemother, 27 (SUPPL. B), pp. 69-73
dc.descriptionDencker, B.B., Larsen, H., Jensen, E.S., Schonheyder, H.C., Nielsen, G.L., Sorensen, H.T., Birth outcome of 1886 pregnancies after exposure to phenoxymethylpenicillin in utero (2002) Clin Microbiol Infect, 8, pp. 196-201
dc.descriptionDinsmoor, M.J., Gibbs, R.S., The role of the newer antimicrobial agents in obstetrics and gynecology (1988) Clin Obstet Gynecol, 31, pp. 423-434
dc.descriptionDonald, P.R., Sellars, S.L., Streptomycin ototoxicity in the unborn child (1981) S Afr Med J, 22, pp. 316-318
dc.descriptionDouthwaite, S., Hansen, L.H., Mauvais, P., Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA (2000) Mol Microbiol, 36, pp. 183-193
dc.descriptionEgen-Lappe, V., Hasford, J., Drug prescription in pregnancy: Analysis of a large statutory sickness fund population (2004) Eur J Clin Pharmacol, 60, pp. 659-666
dc.descriptionEinarson, A., Phillips, E., Mawji, F., D'Alimonte, D., Schick, B., Addis, A., Mastroiacova, P., Koren, G., A prospective controlled multicentre study of clarithromycin in pregnancy (1998) Am J Perinatol, 15, pp. 523-525
dc.descriptionEinarson, A., Shuhaiber, S., Koren, G., Effects of antibacterials on the unborn child: What is known and how should this influence prescribing (2001) Paediatr Drugs, 3, pp. 803-816
dc.descriptionFonseca, M.R.C.C., Fonseca, E., Bergsten-Mendes, G., Prevalence of drug use during pregnancy: A pharmacopepidemiological approach (2002) Rev Saude Publica, 36, pp. 205-212
dc.description(2000) Food and Drug Administration Revision BiaxinR Abbott Laboratories, , http://www.fda.gov/cder/foi/label/2000/50662S29lbl.pdf, searched May 2004
dc.description(2002) Forrest Pharmaceuticals MonurolR FDA Label Information, , http://www.fda.gov/cder/foi/label/2002/50717SLR004_Monurol_lbl.pdf, searched December 2004
dc.descriptionGarland, S.M., O'Reilly, M.A., The risks and benefitis of antimicrobial therapy in pregnancy (1995) Drug Saf, 13, pp. 188-205
dc.descriptionGomes, K.R., Moron, A.F., Silva, R., Siqueira, A.A., Prevalence of use of medicines during pregnancy and its relationship to maternal factors (1999) Rev Saude Publica, 33, pp. 246-254
dc.descriptionGrady, R., Safety profile of quinolone antibiotics in the pediatric population (2003) Pediatr Infect Dis J, 22, pp. 1128-1132
dc.descriptionGreenwood, D., Inhibitors of bacterial protein synthesis (1997) Antimicrobial Chemotherapy, 3rd Ed., 9, pp. 32-48. , Greenwood D (ed.) , Oxford University Press
dc.descriptionHautekeete, M.L., Hepatotoxicity of antibiotics (1995) Acta Gastroenterol Belg, 58, pp. 290-296
dc.descriptionHedstrom, S., Martens, M.G., Antibiotics in pregnancy (1993) Clin Obstet Gynecol, 36, pp. 886-892
dc.descriptionHeikkila, A., Erkkola, R., Review of beta-lactam antibiotics in pregnancy. The need for adjustment of dosage schedules (1994) Clin Pharmacokinet, 27, pp. 49-62
dc.descriptionHeikkila, A., Renkonen, O.V., Erkkola, R., Pharmacokinetics and transplacental passage of imipenem during pregnancy (1992) Antimicrob Agents Chemother, 36, pp. 2652-2655
dc.descriptionHernandez-Diaz, S., Werler, M.M., Walker, A.M., Mitchell, A.A., Folic acid antagonists during pregnancy and the risk of birth defects (2000) N Engl J Med, 30, pp. 1608-1614
dc.descriptionHonein, M.A., Paulozzi, L.J., Himelright, I.M., Lee, B., Cragan, J.D., Patterson, L., Correa, A., Erickson, J.D., Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromcyin: A case review and cohort study (1999) Lancet, 354, pp. 2101-2105
dc.descriptionHooton, T.M., Stamm, W.E., Diagnosis and treatment of uncomplicated urinary tract infection (1997) Infect Dis Clin North Am, 11, pp. 551-581
dc.descriptionJacobson, G.F., Autry, A.M., Kirby, R.S., Liverman, E.M., Motley, R.U., A randomized controlled trial comparing amoxicillin and azithromycin for the treatment of Chlamydia trachomatis in pregnancy (2001) Am J Obstet Gynecol, 184, pp. 1352-1354
dc.descriptionJamjian, C., Biedenbach, D.J., Jones, R.N., In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004 (1997) Antimicrob Agents Chemother, 41, pp. 454-459
dc.descriptionJepsen, P., Skriver, M.V., Floyd, A., Lipworth, L., Schonheyder, H.C., Sorensen, H.T., A population-based study of maternal use of amoxicillin and pregnancy outcome in Denmark (2003) Br J Clin Pharmacol, 55, pp. 216-221
dc.descriptionJohnson, T.N., The development of drug metabolising enzymes and their influence on the susceptibility to adverse drug reactions in children (2003) Toxicology, 192, pp. 37-48
dc.descriptionKnight, M., Adverse drug reactions in neonates (1994) J Clin Pharmacol, 34, pp. 128-135
dc.descriptionKnothe, H., Dette, G.A., Antibiotics in pregnancy: Toxicity and teratogenicity (1985) Infection, 13, pp. 49-51
dc.descriptionLarsen, B., Glover, D.D., Serum erythromycin levels in pregnancy (1998) Clin Ther, 20, pp. 971-977
dc.descriptionLarsen, H., Nielsen, G.L., Sorensen, H.T., Moller, M., Olsen, J., Schonheyder, H.C., A follow-up study of birth outcome in users of pivampicillin during pregnancy (2000) Acta Obstet Gynecol Scand, 79, pp. 379-383
dc.descriptionLewis, J.H., Drug-induced liver disease (2000) Med Clin North Am, 84, pp. 1275-1311
dc.descriptionLoebstein, R., Addis, A., Ho, E., Andreou, R., Sage, S., Donnenfeld, A.E., Schick, B., Koren, G., Pregnancy outcome following gestational exposure to fluoroquinolones: A multicenter prospective controlled study (1998) Antimicrob Agents Chemother, 42, pp. 1336-1339
dc.descriptionLoebstein, R., Koren, G., Clinical relevance of therapeutic drug monitoring during pregnancy (2002) Ther Drug Monit, 24, pp. 15-22
dc.descriptionLoebstein, R., Lalkin, A., Koren, G., Pharmacokinetic changes during pregnancy and their clinical relevance (1997) Clin Pharmacokinet, 33, pp. 328-343
dc.descriptionLouik, C., Werler, M.M., Mitchell, A.A., Erythromycin use during pregnancy in relation to pyloric stenosis (2002) Am J Obstet Gynecol, 186, pp. 288-290
dc.descriptionMantovani, A., Calamandrei, G., Delayed developmental effects following prenatal exposure to drugs (2001) Curr Pharm des, 7, pp. 859-880
dc.descriptionMarynowski, A., Sianozecka, E., Comparison of the incidence of congenital malformations in neonates from healthy mothers and from patients treated because of tuberculosis (1972) Ginekol Pol, 43, pp. 713-715
dc.descriptionMatsuda, S., Suzuki, M., Oh, K., Ishikawa, M., Soma, A., Takada, H., Shimizu, T., Chimura, T., Pharmacokinetic and clinical studies on imipenem/cilastatin sodium in the perinatal period. A study of imipenem/cilastatin sodium in the perinatal co-research group (1988) Jpn J Antibiot, 41, pp. 1731-1741
dc.descriptionMengue, S.S., Schenkel, E.P., Duncan, B.B., Schmidt, M.I., Drug use by pregnant women in six Brazilian cities (2001) Rev Saude Publica, 35, pp. 415-420
dc.descriptionMensa, J., García-Vázquez, E., Vila, J., Macrólidos, cetólidos y estreptograminas (2003) Enferm Infecc Microbiolo Cin, 21, pp. 200-208
dc.description(2004) Invanz - Food and Drug Administration, , www.fda.gov/medwatch/SAFETY/2004/apr_PI/Invanz_PI.pdf, searched December, 2004
dc.descriptionMurphy, J.F., Drugs and pregnancy (1984) Ir Med J, 77, pp. 52-56
dc.descriptionNagai, A., Miyazaki, M., Morita, T., Furubo, S., Kizawa, K., Fukumoto, H., Sanzen, T., Kawamura, Y., Comparative articular toxicity of garenoxacin, a novel quinolone antimicrobial agent, in juvenile beagle dogs (2002) J Toxicol Sci, 27, pp. 219-228
dc.descriptionNiebyl, J.R., Antibiotics and other anti-infective agents in pregnancy and lactation (2003) Am J Perinatol, 20, pp. 405-414
dc.descriptionOrtiz-Ruiz, G., Vetter, N., Isaacs, R., Carides, A., Woods, G.L., Ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults: Combined analysis of two multicentre randomized, double-bind studies (2004) J Antimicrob Chemother, 53, pp. 59-66
dc.description(1997) Parke-Davis: Coly-MycinR M Parenteral, , http://www.fda.gov/cder/ogd/rld/50108s21.pdf, searched December, 2004
dc.descriptionPatel, S.S., Balfour, J.A., Bryson, H.M., Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections (1997) Drugs, 53, pp. 637-656
dc.descriptionPerkins, R.P., Hydrops fetalis and stillbirth in a male glucose-6-phosphate dehydrogenase-deficient fetus possibly due to maternal ingestion of sulfisoxazole
dc.descriptiona case report (1971) Am J Obstet Gynecol, 111, pp. 379-381
dc.description(2003) Pfizer Laboratories: ZithromaxR, , http://www.fda.gov/cder/foi/label/2004/50670slr021,50693slr008, 50730slr011_zithromax_lbl.pdf, searched May, 2004
dc.description(2004) Pharmacia &amp
dc.descriptionUpjohn Company - ZyvoxR Label Information, , http://www.fda.gov/cder/foi/label/2004/21130se5-006,21131se5-007, 21132se5-006_zyvox_lbl.pdf, searched December, 2004
dc.descriptionPhilipson, A., Sabath, L.D., Charles, D., Transplacental passage of erythromycin and clindamycin (1973) N Engl J Med, 288, pp. 1219-1221
dc.descriptionPhilipson, A., Stiernstedt, G., Ehrnebo, M., Comparison of the pharmacokinetics of cephradine and cefazolin in pregnant and non-pregnant women (1987) Clin Pharmacokinet, 12, pp. 136-144
dc.descriptionPiper, J.M., Mitchel, E.F., Ray, W.A., Prenatal use of metronidazole and birth defects: No association (1993) Obstet Gynecol, 82, pp. 348-352
dc.descriptionPreston, S.L., The importance of appropriate antimicrobial dosing: Pharmacokinetic and pharmacodynamic considerations (2004) Ann Pharmacother, 38, pp. S14-S18
dc.descriptionRastogi, N., Goh, K.S., Ruiz, P., Casal, M., In vitro activity of roxithromycin against the Mycobacterium tuberculosis complex (1995) Antimicrob Agents Chemother, 39, pp. 1162-1165
dc.descriptionReid, D.W., Caille, G., Kaufmann, N.R., Maternal and transplacental kinetics of trimethoprim and sulfamethoxazole, separately and in combination (1975) Can Med Assoc J, 112, pp. 67-72
dc.descriptionRodin, P., Hass, G., Metronidazole and pregnancy (1966) Br J Vener Dis, 42, pp. 210-212
dc.descriptionSá Del Fiol, F., Rocha De Mattos Filho, T., Groppo, F.C., Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains (2000) Braz J Infect Dis, 4, pp. 36-42
dc.descriptionSaravanos, K., Duff, P., The quinolone antibiotics (1992) Obstet Gynecol Clin North Am, 19, pp. 529-537
dc.descriptionSchonwald, S., Kuzman, I., Oreskovic, K., Burek, V., Skerk, V., Car, V., Bozinovic, D., Radosevic, S., Azithromycin: Single 1.5 g dose in the treatment of patients with atypical pneumonia syndrome - A randomized study (1999) Infection, 27, pp. 198-202
dc.descriptionShepherd, G.M., Hypersensitivity reactions to drugs: Evaluation and management (2003) Mt Sinai J Med, 70, pp. 113-125
dc.descriptionSorensen, H.T., Larsen, H., Jensen, E.S., Thulstrup, A.M., Schonheyder, H.C., Nielsen, G.L., Czeizel, A., Safety of metronidazole during pregnancy: A cohort study of risk of congenital abnormalities, preterm delivery and low birth weight in 124 women (1999) J Antimicrob Chemother, 44, pp. 854-856
dc.descriptionSorensen, H.T., Skriver, M.V., Pedersen, L., Larsen, H., Ebbesen, F., Schonheyder, H.C., Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides (2003) Scand J Infect Dis, 35, pp. 104-106
dc.descriptionStein, G.E., Single-dose treatment of acute cystitis with fosfomycin tromethamine (1998) Ann Pharmacother, 32, pp. 215-219
dc.descriptionSwaney, S.M., Aoki, H., Ganoza, M.C., Shinabarger, D.L., The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria (1998) Antimicrob Agents Chemother, 42, pp. 3251-3255
dc.descriptionTeppler, H., Gesser, R.M., Friedland, I.R., Woods, G.L., Meibohm, A., Safety and tolerability of ertapenem (2004) J Antimicrob Chemother, 53, pp. 75-81
dc.descriptionSafety of antimicrobial drugs in pregnancy (1987) Med Let Drugs Ther, 29, pp. 61-63
dc.descriptionWeinstein, A.J., Gibbs, R.S., Gallagher, M., Placental transfer of clindamycin and gentamicin in term pregnancy (1976) Am J Obstet Gynecol, 124, pp. 688-691
dc.descriptionWeller, T.M.A., Rees, E.N., Antibacterial use in pregnancy (2000) Drug Saf, 22, pp. 335-338
dc.descriptionWilliams, M.E., Thomas, D., Harman, C.P., Mintz, P.D., Donowitz, G.R., Positive direct antiglobulin tests due to clavulanic acid (1985) Antimicrob Agents Chemother, 27, pp. 125-127
dc.descriptionYabe, K., Yoshida, K., Yamamoto, N., Nishida, S., Ohshima, C., Sekiguchi, M., Yamada, K., Furuhama, K., Diagnosis of quinolone-induced arthropathy in juvenile dogs by use of magnetic resonance (MR) imaging (1997) J Vet Med Sci, 59, pp. 597-599
dc.languageen
dc.publisher
dc.relationPharmazie
dc.rightsfechado
dc.sourceScopus
dc.titleAntibiotics And Pregnancy
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución